Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$43.97 -0.63 (-1.41%)
At close: Sep 29, 2026 · 4:00 PM EDT

Supernus Pharmaceuticals (SUPN) Total Current Liabilities (2011 - 2026)

Updated

Supernus Pharmaceuticals (SUPN) reported Total Current Liabilities of $347.38 million for Q2 2026, up 21.3% from $286.36 million a year earlier but down 7.1% from the prior quarter.

Analysis

Supernus Pharmaceuticals (SUPN) Total Current Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2025, Supernus Pharmaceuticals posted Total Current Liabilities of $338.17 million, up 15.7% from FY2024.

  • Total Current Liabilities has a five-year compound annual growth rate of 6.6% (FY2020 to FY2025).
  • By year, Total Current Liabilities came in at $292.4 million in FY2024 (+0.8%), $290.2 million in FY2023 (-57.8%), $687.96 million in FY2022 (+118.1%) and $315.38 million in FY2021 (+28.7%).
  • Five-year quarterly Total Current Liabilities spans a low of $234.71 million in Q3 2021 and a high of $735.54 million in Q2 2022.
  • Year over year, Total Current Liabilities has now increased in each of the last four quarters, with growth averaging 8.4% over the last eight quarters.
  • The high point for year-over-year Total Current Liabilities in five years was Q3 2022 (growth of 209.3%); the low point was Q2 2023 (a decline of 65.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $373.93 million (Q1 2026), $338.17 million (Q4 2025) and $330.63 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Supernus Pharmaceuticals 2.59 Bn 1.25 Bn 185.39 Mn 347.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 347.38 Mn
Mar 31, 2026 373.93 Mn
Dec 31, 2025 338.17 Mn
Sep 30, 2025 330.63 Mn
Jun 30, 2025 286.36 Mn
Mar 31, 2025 281.77 Mn
Dec 31, 2024 292.40 Mn
Sep 30, 2024 291.51 Mn
Jun 30, 2024 308.66 Mn
Mar 31, 2024 314.55 Mn
Dec 31, 2023 290.20 Mn
Sep 30, 2023 287.53 Mn
Jun 30, 2023 252.59 Mn
Mar 31, 2023 731.55 Mn
Dec 31, 2022 687.96 Mn
Sep 30, 2022 725.99 Mn
Jun 30, 2022 735.54 Mn
Mar 31, 2022 284.56 Mn
Dec 31, 2021 315.38 Mn
Sep 30, 2021 234.71 Mn
API Access

Supernus Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=SUPN&period=max&api_key=YOUR_API_KEY